BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16458962)

  • 1. Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia.
    Kochethu G; Delgado J; Pepper C; Starczynski J; Hooper L; Krishnan S; Fegan C; Pratt G
    Leuk Res; 2006 Sep; 30(9):1113-8. PubMed ID: 16458962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
    Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
    J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.
    Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
    Exp Oncol; 2014 Dec; 36(4):258-61. PubMed ID: 25537220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.
    Høgdall EV; Høgdall CK; Christensen L; Glud E; Blaakaer J; Bock JE; Vuust J; Nørgaard-Pedersen B; Kjaer SK
    Anticancer Res; 2002; 22(3):1859-64. PubMed ID: 12168882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
    Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
    Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
    Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
    Wang AZ; Zhu ZZ; Cong WM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population.
    Sreeja L; Syamala V; Raveendran PB; Santhi S; Madhavan J; Ankathil R
    Cancer Invest; 2008 Feb; 26(1):41-6. PubMed ID: 18181044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.
    Ganster C; Neesen J; Zehetmayer S; Jäger U; Esterbauer H; Mannhalter C; Kluge B; Fonatsch C
    Genes Chromosomes Cancer; 2009 Sep; 48(9):760-7. PubMed ID: 19484764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
    Sturm I; Bosanquet AG; Hummel M; Dörken B; Daniel PT
    BMC Cancer; 2005 Aug; 5():105. PubMed ID: 16109171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
    Enjuanes A; Benavente Y; Bosch F; Martín-Guerrero I; Colomer D; Pérez-Alvarez S; Reina O; Ardanaz MT; Jares P; García-Orad A; Pujana MA; Montserrat E; de Sanjosé S; Campo E
    Cancer Res; 2008 Dec; 68(24):10178-86. PubMed ID: 19074885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of the p53 gene within the codon 72 in lung cancer patients.
    Biros E; Kalina I; Biros I; Kohut A; Bogyiová E; Salagovic J; Stubna J
    Neoplasma; 2001; 48(5):407-11. PubMed ID: 11845987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
    Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
    Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
    Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
    Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.